Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasios Stathis

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Hematological Oncology|June 9, 2021
New drugs and pharmacological interactions in real lifeAnastasios Stathis
The Lancet. Haematology|May 26, 2019
Use of epirubicin to treat diffuse large B-cell lymphomaAnastasios Stathis, Emanuele Zucca
Drug News & Perspectives|September 24, 2010
Targeting Wee1-like protein kinase to treat cancerAnastasios Stathis, Amit Oza
Current Opinion in Hematology|May 23, 2019
Bromodomain and Extra-Terminal domain inhibitors for lymphoid malignanciesFrancesco Bertoni, Anastasios Stathis
Cancer Discovery|December 22, 2017
BET Proteins as Targets for Anticancer TreatmentAnastasios Stathis, Francesco Bertoni
Blood|December 31, 2016
Staining the target: CD37 expression in lymphomasFrancesco Bertoni, Anastasios Stathis
Nature Reviews. Clinical Oncology|January 27, 2010
Advanced pancreatic carcinoma: current treatment and future challengesAnastasios Stathis, Malcolm J Moore
Expert Opinion on Pharmacotherapy|July 1, 2010
Treatment of gastric marginal zone lymphoma of MALT typeAnastasios Stathis, Francesco Bertoni, Emanuele Zucca
Pharmacology & Therapeutics|July 22, 2020
Targeting BET bromodomain proteins in cancer: The example of lymphomasFilippo Spriano, Anastasios Stathis, Francesco Bertoni
Oncology (Williston Park, N.Y.)|April 2, 2014
The management of nongastric MALT lymphomasEmanuele Zucca, Anastasios Stathis, Francesco Bertoni
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Hematological Oncology|June 9, 2021
New drugs and pharmacological interactions in real lifeAnastasios Stathis
The Lancet. Haematology|May 26, 2019
Use of epirubicin to treat diffuse large B-cell lymphomaAnastasios Stathis, Emanuele Zucca
Drug News & Perspectives|September 24, 2010
Targeting Wee1-like protein kinase to treat cancerAnastasios Stathis, Amit Oza
Current Opinion in Hematology|May 23, 2019
Bromodomain and Extra-Terminal domain inhibitors for lymphoid malignanciesFrancesco Bertoni, Anastasios Stathis
Cancer Discovery|December 22, 2017
BET Proteins as Targets for Anticancer TreatmentAnastasios Stathis, Francesco Bertoni
Blood|December 31, 2016
Staining the target: CD37 expression in lymphomasFrancesco Bertoni, Anastasios Stathis
Nature Reviews. Clinical Oncology|January 27, 2010
Advanced pancreatic carcinoma: current treatment and future challengesAnastasios Stathis, Malcolm J Moore
Expert Opinion on Pharmacotherapy|July 1, 2010
Treatment of gastric marginal zone lymphoma of MALT typeAnastasios Stathis, Francesco Bertoni, Emanuele Zucca
Pharmacology & Therapeutics|July 22, 2020
Targeting BET bromodomain proteins in cancer: The example of lymphomasFilippo Spriano, Anastasios Stathis, Francesco Bertoni
Oncology (Williston Park, N.Y.)|April 2, 2014
The management of nongastric MALT lymphomasEmanuele Zucca, Anastasios Stathis, Francesco Bertoni
Pageof 14